miR-191 promotes radiation resistance of prostate cancer through interaction with RXRA
Jessica Ray(University of Toronto), Stanley K. Liu(Sunnybrook Health Science Centre)
Cited by 59
Related Papers
Statin treatment and new-onset diabetes: A review of proposed mechanisms
|Metabolism|2014|214
Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis
|British Journal of Cancer|2017|91
MicroRNA in radiotherapy: miRage or miRador?
|British Journal of Cancer|2015|67
mi<scp>RNA</scp>‐106a and prostate cancer radioresistance: a novel role for <scp>LITAF</scp> in <scp>ATM</scp> regulation
|Molecular Oncology|2018|47
RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer
|Journal of Translational Medicine|2019|36